Estela Rodriguez, Associate Director of Community Outreach-Thoracic Oncology at Sylvester Comprehensive Cancer Center, shared a post on X:
“PRIMOLung26
Great real-world patient case discussion led by Eric K. Singhi.
Next case- Stage IA3 High risk resected adenocarcinoma w STAS+ micropapillary, visceral pleural invasion, NGS: +EGFR del 19, RB1, TP53․”
Pretreatment Risk Model for Radiation-Induced Lymphopenia in Stage III NSCLC: Can We Predict Who Benefits From Durvalumab?
